SHPHHealthcareNano-Cap
Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Shuttle Pharmaceuticals Holdings, Inc. (SHPH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are SHPH insiders buying or selling?
Shuttle Pharmaceuticals Holdings, Inc. insiders reported 3 open-market buys ($154.0K) and 15 sells ($520.7K) across 18 Form 4 filings — a net selling position of $366.7K.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 15, 2026)
Total Form 4 filings
18
SEC EDGAR
Insider filers
11
Insider buys (3)
$154.0K
Insider sells (15)
$520.7K
Insider sentiment
Net sellingNet insider flow of $366.7K in net selling. 3 insider buys in the last 90 days.
Recent SHPH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | HRT FINANCIAL LP | 10% Owner | Sale | 83.1K | $4.48 | $372.7K |
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Purchase | 9.0K | $3.36 | $30.2K |
| Jul 9, 2026 | HRT FINANCIAL LP | 10% Owner | Sale | 29.1K | $3.45 | $100.5K |
| Jul 7, 2026 | HRT FINANCIAL LP | 10% Owner | Sale | 1.2K | $3.31 | $3.9K |
| Jul 2, 2026 | HRT FINANCIAL LP | 10% Owner | Purchase | 4.0K | $3.30 | $13.1K |
| Jul 1, 2026 | HRT FINANCIAL LP | 10% Owner | Purchase | 32.6K | $3.40 | $110.7K |
| Mar 14, 2024 | Chris Senanayake | Director | Sale | 1.6K | $1.61 | $2.6K |
| Jan 2, 2024 | Milton Brown | Director | Sale | 2.9K | $0.46 | $1.4K |
| Dec 21, 2023 | Bette Jacobs | Director | Sale | 4.2K | $0.46 | $1.9K |
| Jan 9, 2023 | Steven M Richards | Director | Sale | 995 | $1.61 | $1.6K |
| Jan 4, 2023 | William Adkins | Other | Sale | 995 | $1.61 | $1.6K |
| Jan 4, 2023 | Milton Brown | Director | Sale | 995 | $1.61 | $1.6K |
| Jan 3, 2023 | Anatoly Dritschilo | CEO and Chairman | Sale | 8.4K | $1.61 | $13.4K |
| Jan 3, 2023 | Tyvin Rich | Chief Medical Officer | Sale | 1.4K | $1.61 | $2.3K |
| Jan 3, 2023 | Mira Jung | Chief Scientific Officer | Sale | 328 | $1.61 | $526.44 |
| Jan 3, 2023 | Bette Jacobs | Director | Sale | 4.4K | $1.61 | $7.0K |
| Dec 31, 2022 | Peter Dritschilo | President and COO | Sale | 3.8K | $1.61 | $6.1K |
| Dec 30, 2022 | Hoek Michael Vander | Chief Financial Officer | Sale | 2.2K | $1.61 | $3.6K |
Showing the 18 most recent of 18 Form 4 filings for Shuttle Pharmaceuticals Holdings, Inc..
Most active SHPH insiders
- HRT FINANCIAL LP6 filings
- Bette Jacobs2 filings
- Milton Brown2 filings
- Anatoly Dritschilo1 filing
- Chris Senanayake1 filing
Ask anything about SHPH insider activity
Use Trabud's AI agent to query Shuttle Pharmaceuticals Holdings, Inc.'s Form 4 history in plain English — "Show me SHPH CEO purchases this year" or compare it against any other ticker.
Open the AI agentSHPH insider trading FAQ
Are Shuttle Pharmaceuticals Holdings, Inc. insiders buying or selling?
Across 18 SEC Form 4 filings, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) insiders reported 3 open-market purchases totaling $154.0K and 15 sales totaling $520.7K. That is a net selling position of $366.7K.
How many insiders trade SHPH stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Shuttle Pharmaceuticals Holdings, Inc.. The most recent filing was accepted on Jul 15, 2026.
Where does Trabud get SHPH insider trading data?
All SHPH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.